| |
| |
|
| Insider
Information: |
Butchofsky Robert |
| Relationship: |
President and CEO, Dir... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,847 |
|
|
Indirect Shares
|
1,400 |
|
|
| Direct
Value |
$118,531 |
|
|
|
Indirect Value
|
$983 |
|
|
| Total
Shares |
170,247 |
|
|
| Total
Value |
$119,513 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
President and CEO, Dir... |
2012-03-20 |
168,847 |
2010-11-05 |
1,400 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2012-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
350 |
168,847 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2010-11-05 |
4 |
B |
$5.60 |
$16,872 |
D/D |
3,000 |
168,497 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2010-06-21 |
4 |
B |
$5.75 |
$28,750 |
D/D |
5,000 |
165,497 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2009-11-03 |
4 |
B |
$3.40 |
$33,999 |
D/D |
10,000 |
160,497 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2009-02-20 |
4 |
B |
$1.80 |
$110,500 |
D/D |
60,000 |
150,497 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2008-10-30 |
4 |
B |
$2.42 |
$36,300 |
D/D |
15,000 |
90,497 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2008-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
650 |
75,497 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President and CEO |
• • – |
2008-07-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,400 |
1,400 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President & CEO |
• • – |
2007-10-26 |
4 |
B |
$4.40 |
$182,116 |
D/D |
39,847 |
74,847 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President & CEO |
• – – |
2007-05-10 |
4 |
B |
$7.40 |
$74,000 |
D/D |
10,000 |
35,000 |
2.74 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President & CEO |
• – – |
2006-03-10 |
4 |
B |
$7.31 |
$98,685 |
D/D |
13,500 |
25,000 |
2.74 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
VP Marketing & Sales Planning |
• – – |
2005-08-01 |
4/A |
S |
$8.66 |
$61,694 |
D/D |
(7,100) |
11,500 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
VP Marketing & Sales Planning |
• – – |
2005-08-01 |
4 |
S |
$8.66 |
$61,694 |
D/D |
(7,100) |
16,400 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
VP Marketing & Sales Planning |
• – – |
2005-05-14 |
4 |
GA |
$0.00 |
$0 |
D/D |
500 |
18,600 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
VP Marketing & Sales PlanningO |
• – – |
2004-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,100 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
